This product is intended for the occlusion treatment of secundum atrial septal defect in patients with congenital heart disease.
Product Features
Patented parachute locking design ensures stable clamping of the occluder. (Granted Patent Publication No.: CN212326463U)
Double-disk inner buckling design enhances the supporting force of the disks, ensuring stable apposition and support of the disks against tissue walls.
Constructed from biopolymer material, it exhibits favorable biocompatibility and facilitates endothelialization.
Combination of concave disk surface and triangular waist buckling design promotes cell deposition and tissue ingrowth.
Made of biodegradable materials, the occluder’s performance matches the in-vivo repair cycle. It gradually degrades after stable endothelialization, achieving effective occlusion and completion of autologous tissue reconstruction.
该产品用于先天性心脏病继发孔型房间隔缺损的封堵治疗。
产品特点
专利降落伞锁定设计，确保封堵器稳定夹持。（专利公开号(授权)：CN212326463U）
双盘内扣设计，提升盘面支撑力，保障盘面贴壁及支撑稳定。
选择生物高分子材料，生物相容性好，利于内皮化。
盘面内凹结合腰部三角扣合设计，利于细胞沉积与组织填充。
采用生物可降解材料，封堵器性能与体内修复周期相匹配，内皮化稳定后逐步降解，实现有效封堵及自体组织再造完成。